Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

CRN Opposes Duplicative Mandates for Supplement Manufacturers

July 1, 2011 By Bio-Medicine.Org

WASHINGTON, July 1, 2011 /PRNewswire-USNewswire/ — In
response to yesterday’s introduction of
S. 1310, the
Dietary Supplement Labeling Act of 2011
, by Senator
Richard Durbin (D-IL), the Council for Responsible Nutrition (CRN),
the leading trade association representing the dietary supplement
industry, issued the following statement.

Statement by Steve Mister, President & CEO, CRN:

“CRN opposes the Dietary Supplement Labeling Act of 2011 because
it is a misguided bill that doesn’t address the concerns raised by
Senator Durbin, but instead creates more bureaucracy for an already
resource-challenged agency and more red tape and costs for industry
while doing nothing to further protect consumers from his concerns.
Instead of urging FDA to use its current enforcement authority to
isolate and punish those companies that are not following the law,
this bill serves to punish all responsible companies with its
overreaching mandates.  

“The bill contains duplicative requirements that already exist
under current law that gives FDA the proper legal authority to take
action to protect consumers and maintain safety standards. FDA
needs to continue working toward becoming a more efficient steward
of its resources, and we continuously call on the Agency to use its
power under the law.  We urge Senator Durbin to join us in
that effort.  

“However, to pile on more work for an underfunded agency already
struggling to accomplish everything currently on its plate is both
counterproductive and unnecessary.  Further, in the midst of
an economic downturn and a robust debate on the state of health in
America, Senator Durbin along with many of his colleagues, have
correctly indicated that well-care instead of sick-care is the
direction that America must move towards in seeking to lower
healthcare related expenses and burdens. This legislation only
removes us from that path by placing undue hurdles in f

‘/>”/>

SOURCE

Related Articles Read More >

The most innovative medical devices of 2026
An illustration showing Corcym's Memo 4D Curve's laser-cut nitinol core.
Laser-cut nitinol and a layered design let these cardiac implants flex
Reconstructed 3D fluorescence image of the stained biohybrid mesh-tissue integration. The red, green, and blue colors correspond to the mesh, F-actin, and nuclei, respectively.
Researchers mesh electronics with human cells to develop living battery
A photo of the Paradromics Connexus brain-computer interface on a fingertip.
How Paradromics designed its Connexus brain-computer interface system
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe